EC17 imaging contrast agent

DRUG2 trials

Sponsors

University of Pennsylvania, VA Office of Research and Development

Conditions

AdenocarcinomaLung CancerLung and Pleural MalignanciesNeoplasmsNodules

Phase 1

Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)

CompletedNCT01778920

University of PennsylvaniaAdenocarcinoma, Lung and Pleural Malignancies, Neoplasms +1

Start: 2012-04-30End: 2016-05-31Updated: 2016-05-17

Intraoperative Imaging of Pulmonary Adenocarcinoma

WithdrawnNCT02653612

VA Office of Research and DevelopmentLung Cancer

Start: 2016-01-01End: 2018-02-26Updated: 2018-03-02